手机版 客户端
《CANCER CHEMOTHERAPY AND PHARMACOLOGY》杂志封面

《CANCER CHEMOTHERAPY AND PHARMACOLOGY》中科院JCR分区

  • 2025年3月升级版:
  • 大类小类学科Top综述期刊
    医学 4区
    ONCOLOGY
    肿瘤学
    4区
    PHARMACOLOGY & PHARMACY
    药学
    4区

  • 2023年12月升级版:
  • 大类小类学科Top综述期刊
    医学 4区
    PHARMACOLOGY & PHARMACY
    药学
    3区
    ONCOLOGY
    肿瘤学
    4区

    《CANCER CHEMOTHERAPY AND PHARMACOLOGY》期刊简介:

    Addressing a wide range of pharmacologic and oncologic concerns on both experimental and clinical levels, Cancer Chemotherapy and Pharmacology is an eminent journal in the field. The primary focus in this rapid publication medium is on new anticancer agents, their experimental screening, preclinical toxicology and pharmacology, single and combined drug administration modalities, and clinical phase I, II and III trials. It is essential reading for pharmacologists and oncologists giving results recorded in the following areas: clinical toxicology, pharmacokinetics, pharmacodynamics, drug interactions, and indications for chemotherapy in cancer treatment strategy.

  • 浏览下载本刊EndNote stylesEndNote styles
  • 《CANCER CHEMOTHERAPY AND PHARMACOLOGY》其他相关信息:

    《CANCER CHEMOTHERAPY AND PHARMACOLOGY》评估说明

      《CANCER CHEMOTHERAPY AND PHARMACOLOGY》发布于爱科学网,并永久归类相关SCI期刊导航类别中,本站只是硬性分析 "《CANCER CHEMOTH PHARM》" 杂志的可信度。学术期刊真正的价值在于它是否能为科技进步及社会发展带来积极促进作用。"《CANCER CHEMOTH PHARM》" 的价值还取决于各种因素的综合分析。

    此文由爱科学编辑!:首页 > SCI期刊 > 医学 » CANCER CHEMOTHERAPY AND PHARMACOLOGY

    《CANCER CHEMOTHERAPY AND PHARMACOLOGY》投稿经验分享